Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver involvement in giant cell arteritis

Y Ilan1, E Ben-Chetrit

  • 1Division of Medicine Hadassah University Hospital, Jerusalem, Israel.

Clinical Rheumatology
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving hand hygiene in hospitals: A comparative study using body-worn cameras and direct observation.

American journal of infection control·2025
Same author

Measles-related hospitalizations and associated complications in Jerusalem, 2018-2019.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH.

Clinical and experimental immunology·2018
Same author

An unforeseen complication of a folk remedy for joint pain.

Medecine et maladies infectieuses·2018
Same author

Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift.

BMC gastroenterology·2017
Same author

The risk for Clostridium difficile colitis during hospitalization in asymptomatic carriers.

The Journal of hospital infection·2017
Same journal

Serum ferritin as a predictor of major adverse cardiovascular events in Takayasu arteritis: a two-center retrospective cohort study.

Clinical rheumatology·2026
Same journal

Inverse association between metabolic dysfunction-associated steatotic liver disease and incident rheumatoid arthritis in middle-aged adults with chronic hepatitis B.

Clinical rheumatology·2026
Same journal

Extension of cytokines' role in Behcet's disease associated peripheral neuropathy.

Clinical rheumatology·2026
Same journal

Renal osteodystrophy with near-complete bilateral sacroiliac ankylosis: a bat-like pelvic configuration on CT.

Clinical rheumatology·2026
Same journal

Serum exosomal tRNA-derived small RNAs as diagnostic biomarkers for primary Sjögren's syndrome: a combined model with autoantibodies.

Clinical rheumatology·2026
Same journal

Monosodium urate crystals induce lytic macrophage death partially dependent on both pyroptosis and necroptosis.

Clinical rheumatology·2026
See all related articles

Giant cell arteritis (GCA) can affect liver function, often presenting as cholestatic liver injury. Steroid treatment typically resolves these liver test abnormalities in GCA patients.

Area of Science:

  • Vascular Medicine
  • Hepatology
  • Rheumatology

Background:

  • Giant cell arteritis (GCA) is a systemic vasculitis affecting large and medium-sized arteries, predominantly in individuals over 50.
  • Hepatic involvement is a recognized, though less common, manifestation of GCA.
  • Liver function abnormalities can be the sole presenting feature or accompany typical GCA symptoms.

Purpose of the Study:

  • To investigate the prevalence and pattern of liver involvement in patients with GCA.
  • To describe the clinical course and response to treatment of hepatic dysfunction in GCA.
  • To review the existing literature on the association between GCA and liver test abnormalities.

Main Methods:

  • Retrospective review of 56 patients diagnosed with GCA over a 15-year period.

Related Experiment Videos

  • Analysis of liver function tests (LFTs) in patients with GCA.
  • Correlation of LFT abnormalities with GCA diagnosis and treatment response.

    • Main Results:

    • Twelve out of 56 GCA patients (21.4%) exhibited abnormal liver function tests.
    • The majority of LFT abnormalities were of a cholestatic pattern.
    • All patients with cholestatic liver injury showed complete resolution with corticosteroid therapy.

    Conclusions:

    • Disturbed liver function tests, particularly cholestatic, are a significant finding in a subset of GCA patients.
    • Prompt diagnosis and treatment of GCA with corticosteroids are crucial for resolving hepatic manifestations.
    • Awareness of potential liver involvement is important for comprehensive management of GCA.